Sherrington Robin Xenon Pharmaceuticals Inc. (XENE) insider trading activity

Sherrington Robin is EVP, Strategy & Innovation of Xenon Pharmaceuticals Inc.. Currently has a direct ownership of 8,398 shares of XENE, which is worth approximately $358,342. The most recent transaction as insider was on Mar 07, 2024, when has been sold 7,137 shares (Common Shares) at a price of $46.23 per share, resulting in proceeds of $329,943. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 8.4K

0% 3M change

0% 12M change

Total Value Held $358,342

SHERRINGTON ROBIN Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 07 2024	SELL Open market or private sale	$329,943 $46.23 p/Share	7,137 Reduced 45.94%	8,398 Common Shares
Mar 07 2024	SELL Payment of exercise price or tax liability	$69,123 $45.96 p/Share	1,504 Reduced 8.83%	15,535 Common Shares
Mar 07 2024	BUY Exercise of conversion of derivative security	$85,113 $9.85 p/Share	8,641 Added 33.93%	16,824 Common Shares
Dec 29 2023	SELL Other acquisition or disposition	-	8,398 Reduced 50.0%	8,398 Common Shares
Sep 01 2022	SELL Open market or private sale	$1,685,392 $38.41 p/Share	43,879 Reduced 72.32%	16,796 Common Shares
Sep 01 2022	SELL Payment of exercise price or tax liability	$237,556 $38.81 p/Share	6,121 Reduced 9.16%	60,675 Common Shares
Sep 01 2022	BUY Exercise of conversion of derivative security	$237,500 $4.75 p/Share	50,000 Added 42.81%	66,796 Common Shares
Aug 31 2022	SELL Payment of exercise price or tax liability	$59,516 $37.86 p/Share	1,572 Reduced 3.96%	38,148 Common Shares
Aug 31 2022	SELL Open market or private sale	$823,547 $38.57 p/Share	21,352 Reduced 55.97%	16,796 Common Shares
Aug 31 2022	BUY Exercise of conversion of derivative security	$83,430 $3.71 p/Share	22,488 Added 36.15%	39,720 Common Shares
Mar 04 2022	SELL Open market or private sale	$662,155 $30.5 p/Share	21,710 Reduced 55.75%	17,232 Common Shares
Mar 04 2022	SELL Payment of exercise price or tax liability	$21,868 $31.42 p/Share	696 Reduced 2.08%	32,770 Common Shares
Mar 04 2022	BUY Exercise of conversion of derivative security	$27,180 $3.67 p/Share	7,406 Added 15.98%	38,942 Common Shares
May 28 2021	SELL Payment of exercise price or tax liability	$79,725 $18.91 p/Share	4,216 Reduced 9.92%	38,299 Common Shares
May 28 2021	SELL Open market or private sale	$114,120 $18.81 p/Share	6,067 Reduced 15.84%	32,232 Common Shares
May 28 2021	BUY Exercise of conversion of derivative security	$97,989 $3.81 p/Share	25,719 Added 38.84%	40,491 Common Shares

Sherrington Robin

EVP, Strategy & Innovation

Burnaby, A1

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells XENE shares.

Notify only if

Value

Insider Trading

Get notified when an Xenon Pharmaceuticals Inc. insider buys or sells XENE shares.

Notify only if

Operation

Value

Type

News

Receive news related to Xenon Pharmaceuticals Inc.

Track Activities on XENE

Account